Literature DB >> 18090427

A model for management of behavioral symptoms in frontotemporal lobar degeneration.

Jennifer Merrilees1.   

Abstract

Frontotemporal lobar degeneration is a neurologic condition that manifests profound behavioral, personality, and language symptoms. These changes, often unique to each person, may include social misconduct, eating disturbances, apathy, emotional blunting, childlike behavior, habits and rituals, executive dysfunction, and marked difficulty with speech and language. These symptoms occur as the result of cell loss in discrete areas of the brain, the frontal and/or anterior temporal lobes. Little is known about effective management of the behavioral symptoms that result from this disease. The purpose of this paper is to describe a model that could be used in the assessment and potential management of frontotemporal lobar degeneration behavioral symptoms. Suggestions for interventions are given for some of the more common FTD behaviors. The impact of behavioral symptoms on the family caregiver is discussed along with strategies for supportive services and recommendations for future study.

Entities:  

Mesh:

Year:  2007        PMID: 18090427     DOI: 10.1097/WAD.0b013e31815bf774

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  18 in total

Review 1.  Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.

Authors:  Cynthia Barton; Robin Ketelle; Jennifer Merrilees; Bruce Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

2.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

Review 3.  Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.

Authors:  Geoffrey A Kerchner; Maria Carmela Tartaglia; Adam Boxer
Journal:  Expert Rev Neurother       Date:  2011-05       Impact factor: 4.618

Review 4.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 5.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

6.  Accessing community-based and long-term care services: challenges facing persons with frontotemporal dementia and their families.

Authors:  Darby Morhardt
Journal:  J Mol Neurosci       Date:  2011-08-09       Impact factor: 3.444

Review 7.  Diagnosis and management of behavioral variant frontotemporal dementia.

Authors:  Peter S Pressman; Bruce L Miller
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

Review 8.  Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia.

Authors:  Edward D Huey; Nicole Armstrong; Parastoo Momeni; Jordan Grafman
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

Review 9.  Diagnosis and management of behavioral issues in frontotemporal dementia.

Authors:  Masood Manoochehri; Edward D Huey
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 10.  Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia.

Authors:  Kathleen B Kortte; Emily J Rogalski
Journal:  Int Rev Psychiatry       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.